Clinical Trials · NCT07649421
PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- West China Hospital
- Enrollment
- 254
- Start date
- Sep 2026
- Locations
- 1 site, China
- Primary endpoint
- 3-Year Radiographic Progression-Free Survival (rPFS)